These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 1437798)

  • 1. [Evaluation of loss of active heparin in the peritoneal cavity during intermittent peritoneal dialysis].
    Kuźniak J; Grzegorzewska A
    Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):123-5. PubMed ID: 1437798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of sulfinpyrazone on peritoneal and renal clearance in patients with chronic renal failure treated by intermittent peritoneal dialysis].
    Grzegorzewska A; Antoniewicz K; Kuźniak J; Zawadzka E
    Przegl Lek; 1990; 47(10):686-90. PubMed ID: 2089444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Peritoneal equilibration test].
    Morduchowicz G; Feldman T; van Dyk DJ; Boner G
    Harefuah; 1990 Mar; 118(6):312-5. PubMed ID: 2347531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of peritoneal dialysis using dialysis fluid of modernized composition].
    Janicka L; Ksiazek A; Solski J; Majdan M; Bocheńska-Nowacka E; Bednarek-Skublewska A; Spasiewicz D
    Wiad Lek; 1990 Jun; 43(12):564-71. PubMed ID: 2260311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of intraperitoneal heparin during peritoneal dialysis.
    Furman KI; Gomperts ED; Hockley J
    Clin Nephrol; 1978 Jan; 9(1):15-8. PubMed ID: 630740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate clearance by high-flux hemodialysis and peritoneal dialysis: a case report.
    Murashima M; Adamski J; Milone MC; Shaw L; Tsai DE; Bloom RD
    Am J Kidney Dis; 2009 May; 53(5):871-4. PubMed ID: 19339090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Levels of plasma proteins in patients with ene stage renal failure treated with peritoneal dialysis with an addition of furosemide to dialysis fluid].
    Grzegorzewska A; Krzymański M; Antoniewicz K
    Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):137-40. PubMed ID: 8090666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin pharmacokinetics in patients undergoing chronic intermittent peritoneal dialysis.
    Glew RH; Pavuk RA; Shuster A; Alfred HJ
    Int J Clin Pharmacol Ther Toxicol; 1982 Dec; 20(12):559-63. PubMed ID: 7152738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxidase activity in peritoneal neutrophils of patients with terminal renal failure treated by intermittent peritoneal dialysis.
    Sułowicz W; Hanicki Z; Labza H; Basta A
    Med Interne; 1990; 28(2):135-8. PubMed ID: 2176739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of intraperitoneal furosemide administration on levels of +proteins+ in plasma and signs of their ability to be dialyzed during intermittent peritoneal dialysis].
    Grzegorzewska A; Krzymański M; Antoniewicz K
    Pol Tyg Lek; 1991 Jan 21-28; 46(4-5):67-70. PubMed ID: 1845696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peritoneal fluid agitation and dialysis dose estimation in automatic peritoneal dialysis].
    Esteve V; Ponz E; Marquina D; Blasco C; Martínez Ocaña JC; Mañé N; García M
    Nefrologia; 2006; 26(2):267-9. PubMed ID: 16808266
    [No Abstract]   [Full Text] [Related]  

  • 12. [Indoprofen in chronic intermittent peritoneal dialysis: effects in the clearance of small molecules and protein loss].
    García-Ortiz R; Campos G; Silva G; Gómez M; Uribe C; Herrera O
    Rev Med Chil; 1989 May; 117(5):528-33. PubMed ID: 2519164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of various pharmacologic and conventional methods of increasing the effectiveness of peritoneal dialysis. V. Usefulness of selected parameters of peritoneal transfer for evaluating the effectiveness of intermittent peritoneal dialysis].
    Grzegorzewska A
    Przegl Lek; 1989; 46(5):440-7. PubMed ID: 2772244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transport processes--ultrafiltration in peritoneal dialysis].
    Nesić V; Dimitrijević Z; Stojimirović B
    Srp Arh Celok Lek; 1996; 124 Suppl 1():159-62. PubMed ID: 9102889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of new dialysis solutions on clinical results in patients treated with peritoneal dialysis].
    Haag-Weber M
    Wien Klin Wochenschr; 2005; 117 Suppl 6():89-97. PubMed ID: 16437339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of anaesthesia on fluid and solute transport in a C57BL6 mouse model of peritoneal dialysis.
    Shin SK; Kamerath CD; Gilson JF; Leypoldt JK
    Nephrol Dial Transplant; 2006 Oct; 21(10):2874-80. PubMed ID: 16877489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protein loss during maintenance peritoneal dialysis (author's transl)].
    Selgas R; Beberide JM; Villar A; Quevedo E; Rodríguez Carmona A; Gómez P; Sánchez Sicilia L
    Med Clin (Barc); 1982 Jul 1-31; 79(3):114-7. PubMed ID: 7109766
    [No Abstract]   [Full Text] [Related]  

  • 18. How peritoneal dialysis works.
    Kelley KT
    Nephrol Nurs J; 2004; 31(5):481-2, 488-9; quiz 490-1. PubMed ID: 15518250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of dialysis dose during combination therapy with peritoneal dialysis and hemodialysis.
    Kawanishi H; Moriishi M; Tsuchiya S
    Adv Perit Dial; 2007; 23():135-9. PubMed ID: 17886620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cimetidine clearance during intermittent and chronic peritoneal dialysis.
    Hyneck ML; Murphy JF; Lipschutz DE
    Am J Hosp Pharm; 1981 Nov; 38(11):1760-2. PubMed ID: 7304634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.